New York State Common Retirement Fund Sells 3,100 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

New York State Common Retirement Fund reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 477,102 shares of the medical equipment provider’s stock after selling 3,100 shares during the period. New York State Common Retirement Fund’s holdings in Intuitive Surgical were worth $249,028,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the 4th quarter valued at about $36,000. Finally, Sierra Ocean LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $40,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $601.17 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company’s 50 day moving average price is $561.88 and its 200-day moving average price is $522.27. The company has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ISRG. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective on the stock. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Leerink Partners raised their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.